Panel Discussion

Tuesday, March 11, 2025

10:32 AM - 11:00 AM ET

Panel Moderator(s)

Steven L. Goldberg, MD, FSCAI, FACC

Interventional Cardiologist
SL Goldberg MD A Medical Corporation
Monterey, California, United States

No relationships to disclose
Andrew M. Goldsweig, MD, MS

Director, Cardiac Catheterization Laboratory; Director, Cardiovascular Clinical Research
Baystate Medical Center
West Hartford, Connecticut, United States

No relationships to disclose

Panel Discussant(s)

Hans R. Figulla, MD, PhD

Full Professor emeritus
Universitätsklinikum Jena
Jena, Thuringen, Germany

No relationships to disclose
Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC

Interventional Cardiologist
John Muir Health Cardiovascular Institute
San Francisco, California, United States

No relationships to disclose
Aaron V. Kaplan, MD, FSCAI, FACC, FNAI

Professor of Medicine
Dartmouth Health Geisel School of Medicine at Dartmouth
Lebanon, New Hampshire, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Conformal Medical, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Horst Sievert, MD, FSCAI, FACC, FESC

Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany

No relationships to disclose

Disclosure(s):

Steven L. Goldberg, MD, FSCAI, FACC: Abbott Labs: Consultant (Ongoing); Boston Scientific, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Celonova, Contego, Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech: Consulting Fees (e.g., advisory boards) (Ongoing)

Andrew M. Goldsweig, MD, MS: Conformal Medical: Consultant (Ongoing); Philips: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Hans R. Figulla, MD, PhD: devie medical GmbH: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); P&F GmbH, Vienna: License (Ongoing)

Gary Gershony, MD, FACC, FSCAI, FAHA, FRCPC: AtaCor Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Aaron V. Kaplan, MD, FSCAI, FACC, FNAI: Abbott Vascular, Medtronic, Boston Scientific: Grant/Research Support (Ongoing); Conformal Medical, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Horst Sievert, MD, FSCAI, FACC, FESC: Abbott, Ablative Solutions, Adona Medical, Akura Medical, Ancora Heart, Append Medical, Axon, Bavaria Medizin Technologie GmbH, BioRefine, Bioventrix, Boston Scientific, Canon, Cardiac Dimensions, Cardiac Success, Cardimed, Cardionovum, Contego: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Coramaze, Croivalve, CSL Behring LLC, CVRx, Dinova, Endobar, Endologix, Endomatic, Esperion Therapeutics, Inc., Hangzhou Nuomao Medtech, Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor, Renal Guard, Shifamed, Terumo, Tonic Medical: Study honoraria to institution, travel expenses, consulting fees (Ongoing); Trisol, TruLeaf, Vascular Dynamics, Vectorious Medtech, Venus, Venock, Vivasure Medical, Vvital Biomed, Whiteswell, Xenter: Study honoraria to institution, travel expenses, consulting fees (Ongoing)